What is the appearance of acute blood on CT, MRI (Magnetic Resonance Imaging) T1, T2, DWI (Diffusion-Weighted Imaging), and SWAN (Susceptibility-Weighted Imaging)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Blood Appearance on Neuroimaging

Acute blood appears hyperdense (bright white) on CT, isointense to hypointense on T1-weighted MRI, markedly hypointense (dark) on T2-weighted MRI, hypointense (dark) on DWI, and markedly hypointense with blooming artifact on SWAN/gradient-echo sequences. 1

CT Imaging of Acute Blood

  • Acute hemorrhage appears hyperdense (high density/bright) on non-contrast CT due to the high protein content of hemoglobin, with Hounsfield values consistent with acute blood 2, 1
  • CT should ideally be performed within 1 week of symptom onset to reliably demonstrate the high density characteristic of recent hemorrhage 2
  • The American Heart Association recommends CT as the primary modality for excluding hemorrhage before thrombolytic therapy due to its reliable and consistent hyperdensity in the acute phase 1
  • CT has been the assumed gold standard for detecting acute intracranial hemorrhage, though this is based primarily on practical experience and level C studies 2

MRI T1-Weighted Imaging of Acute Blood

  • In the first week, acute blood appears isointense to brain tissue on T1-weighted images due to increased deoxyhemoglobin 2
  • The central portion of acute hemorrhage may show isointense signal corresponding to the acute clot 3
  • Acute thrombus may be of low intensity on T1-weighted sequences in the very early phase 2

MRI T2-Weighted Imaging of Acute Blood

  • Acute hemorrhage demonstrates markedly diminished signal intensity (hypointensity) centrally on T2-weighted images relative to surrounding white matter 4
  • In the first week, venous thrombus and acute blood appear hypointense on T2-weighted images owing to increased deoxyhemoglobin 2
  • Surrounding edema may produce moderately increased signal intensity (hyperintensity) of adjacent white matter on T2-weighted images 4

DWI (Diffusion-Weighted Imaging) of Acute Blood

  • Acute hemorrhage appears hypointense (dark) on DWI due to susceptibility effects from blood products, which is the critical distinction from acute ischemia that appears hyperintense (bright) 1
  • DWI uses echo-planar imaging sequences that are inherently sensitive to susceptibility changes caused by intraparenchymal blood products 2, 1
  • Acute hemorrhage may show hyperintense signal on DWI in some cases, but this is typically accompanied by areas of hypointensity 3

Critical Pitfall to Avoid

  • Do not confuse acute ischemia with acute hemorrhage on DWI: acute ischemia is hyperintense (bright), while acute hemorrhage is hypointense (dark) due to susceptibility effects 1
  • This distinction is essential for treatment decisions, as thrombolytic therapy is contraindicated in hemorrhage 2

SWAN/Gradient-Echo/Susceptibility-Weighted Imaging of Acute Blood

  • Acute blood demonstrates markedly hypointense signal (blooming artifact/signal dropout) on gradient-echo and susceptibility-weighted sequences 2, 1
  • Magnetic susceptibility imaging (T2*-weighted sequences including SWAN, GRE, SWI) detects very small amounts of deoxyhemoglobin and other paramagnetic compounds 2, 5
  • These sequences are particularly sensitive for detecting acute hemorrhage, with gradient-echo MRI demonstrating 96% concordance with CT for acute hemorrhage detection 2
  • The American Heart Association states that gradient-echo sequences reliably detect intracranial hemorrhage, allowing MRI to serve as the sole initial imaging modality for acute stroke evaluation 2, 5
  • A thrombosed dural sinus or acute hemorrhage demonstrates low signal on gradient-echo and susceptibility-weighted images due to paramagnetic products of deoxyhemoglobin 2

Practical Clinical Algorithm

For rapid hemorrhage exclusion:

  • Use non-contrast CT as first-line imaging, where hyperdense blood is immediately visible 1
  • CT can be performed and interpreted within minutes, making it ideal for emergency triage 2

If MRI is the initial modality:

  • Include gradient-echo (GRE) or susceptibility-weighted imaging (SWI) sequences, as these reliably detect hemorrhage as hypointense signal 2, 1
  • A streamlined MRI protocol including DWI, FLAIR, gradient-echo can be performed in approximately 10 minutes 5
  • MRI with gradient-echo sequences has been shown to be at least as accurate as CT for detecting acute intracranial hemorrhage 2

Time-Dependent Evolution Caveat

  • The MRI appearance of blood products evolves over time based on hemoglobin breakdown, with deoxyhemoglobin causing the characteristic hypointensity on T2-weighted and gradient-echo sequences specifically in the acute phase (first week) 2, 1, 4
  • By the second week, thrombus contains methemoglobin, which results in hyperintensity on both T1- and T2-weighted images, representing the subacute phase 2

References

Guideline

Acute Blood Appearance on CT and MRI DWI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

CT and MRI in acute hemorrhagic stroke.

Cerebrovascular diseases (Basel, Switzerland), 2000

Research

MR imaging of hemorrhagic conditions of the head and neck.

Radiographics : a review publication of the Radiological Society of North America, Inc, 1988

Guideline

Role of Imaging in Acute Ischemic Stroke Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.